Single-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study.

Abstract

ABSTRACT:

We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17 (20%) of 85 women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar after single-dose azithromycin.

• Authors: Remco P H Peters, Liteboho Maduna, Marleen M Kock, James A McIntyre, Jeffrey D Klausner, Andrew Medina-Marino
• Journal: Sexually transmitted diseases (Sex Transm Dis) Vol. 48 Issue 2 Pg. e15-e17 (02 01 2021) ISSN: 1537-4521 [Electronic] United States
• PMID: 33448728 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.

Chemical References

• Azithromycin

Topics

• Azithromycin (therapeutic use)
• Chlamydia trachomatis
• Female
• HIV Infections (complications, drug therapy, epidemiology)
• Homosexuality, Male
• Humans
• Lymphogranuloma Venereum (drug therapy, epidemiology)
• Male
• South Africa (epidemiology)